Clinical Trial Update: Fluorescence Imaging of IBD and RA Using Adalimumab-800CW [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for fluorescence imaging using Adalimumab-800CW to visualize inflammation in inflammatory bowel disease and rheumatoid arthritis. …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Inflammatory Bowel Disease
• Rheumatoid Arthritis

Drugs mentioned

• ADALIMUMAB (ADALIMUMAB-AATY)
• Adalimumab-800CW (adalimumab-800CW)

Snippet

Sponsor: University Medical Center Groningen | Conditions: IBD, Rheumatoid Arthritis | Phase 2 | Status: RECRUITING